Tenidap in Patients with Rheumatoid Arthritis

References

• Kadin S B, Carty T J, Moore P F, Otteraess I G, Showell H J, Weisman A. 2-Acyl-2-oxoindole-l-carboxamides, a new class of antiinflammatory agents inhibiting arachidonic acid metabolism and interleukin-1 (IL-1) biosynthesis. Abstr Pap Am Chem Soc 1989; 197: 67
   Google Scholar
• Mylari B L, Carty T J, Moore P F, Zembrowski WJ. 1,2-Dihydro-l-oxopyrrolo[3,2,l-kl] pheno-thiazine-2-carboxamides and congeners, dual cyclooxygenase/5-lipoxygenase inhibitors with antiinflammatory activity. J Med Chem 1990; 33: 2019–24
   PubMedGoogle Scholar
• Carty T J, Showell H J, Loose L D, Kadin SB. Inhibition of both 5-lipoxygenase (5-LO) and cyclooxygenase (CO) pathways of arachidonic acid (AA) metabolism by CP-66,248. Arthritis Rheum 1988; 31: S89
   Google Scholar
• Sipe J D, Bartle L M, Loose LD. Modification of proinflammatory cytokine production by the antirheumatic agents teni-dap and naproxen. A possible correlate with clinical acute phase response. J. Immunol 1992; 148: 480–4
   PubMed Web of Science ®Google Scholar
• Dingle J T, Leeming M RG, Martindale JJ. Effect of tenidap on cartilage integrity in vitro. Ann Rheum Dis 1993; 52: 292–9
   PubMed Web of Science ®Google Scholar
• Pettipher ER. Pathogenesis and treatment of chronic arthritis. Sci Prog 1989; 73: 521–34
   PubMedGoogle Scholar
• Ito A, Itoh Y, Sasaguri Y, Morimatsu M, Mori Y. Effects of interleukin-6 on the metabolism of connective tissue components in rheumatoid synovial fibroblasts. Arthritis Rheum 1992; 35: 1197–1201
   PubMedGoogle Scholar
• Elliott M J, Maini R N, Feldmann M, Long-Fox A, Charles P, Katsikis P, et al. Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor β. Arthritis Rheum 1993; 36: 1681–90
   PubMed Web of Science ®Google Scholar
• Gauldie J, Sauder D N, McAdam K PWJ, Dinarello CA. Purified interleukin-1 (IL-1) from human monocytes stimulates acute-phase protein synthesis by rodent hepatocytes in vitro. Immunology 1987; 60: 203–7
   PubMed Web of Science ®Google Scholar
• Heinrich P C, Castell J V, Andus T. Interleukin-6 and the acute phase response. Biochem J 1990; 265: 621–36
   PubMed Web of Science ®Google Scholar
• Loose L D, Sipe J D, Kirby D S, Kraska A R, Weiner E S, Shanahan WR, et al. Reduction of acute-phase proteins with tenidap sodium, a cytokine-modulating anti-rheumatic drug. Br J Rheumatol 1993; 32: 19–25, Suppl 3
   PubMedGoogle Scholar
• Mallya R K, de Beer F C, Berry H, Hamilton E DB, Mace B EW, Pepys M. Correlation of clinical parameters of disease activity in rheumatoid arthritis with serum concentration of C-reactive protein and erythrocyte sedimentation rate. J. Rheumatol 1982; 9: 3224–8
   Web of Science ®Google Scholar
• Pepys M B, de Beer F C, Dyck RF, et al. Clinical measurement of serum C-reactive protein in monitoring and differential diagnosis of inflammatory diseases and tissue necrosis and in the recognition and management of intercurrent infection. Ann NY Acad Sci 1982; 389: 459–60
   Google Scholar
• Ballou S P, Kushner I. C-reactive protein and the acute phase response. Adv Intern Med 1992; 37: 313–36
   PubMedGoogle Scholar
• Dawes P T, Fowler P D, Clarke S, Fisher S, Lawton A, Shadforth MF. Rheumatoid arthritis: treatment which controls the C-reactive protein and erythrocyte sedimentation rate reduces radiological progression. Br J. Rheumatol 1986; 25: 44–9
   PubMedGoogle Scholar
• Larsen A. The relation of radiographic changes to serum acute-phase proteins and rheumatoid factor in 200 patients with rheumatoid arthritis. 1988; 17: 123–9
   Google Scholar
• van der Heijde D MFM, Van Riel P LCM, Van Leeuwen M A, van't Hof M A, Van Rijswijk M H, van de Putte L BA. Prognostic factors for radiographic damage and physical disability in early rheumatoid arthritis. A prospective follow-up study of 147 patients. Br J. Rheumatol 1992; 31: 519–25
   PubMedGoogle Scholar
• Arnett F C, Edworthy S M, Block D A, McShane D J, Fries J F, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315–24
   PubMed Web of Science ®Google Scholar
• Meenan R F, Gertman P M, Mason JH. Measuring health status in arthritis. The Arthritis Impact Measurement Scales. Arthritis Rheum 1980; 23: 146–52
   PubMed Web of Science ®Google Scholar
• Brown J H, Kazis L E, Spitz P W, Gertman P, Fries J F, Meenan RF. The dimensions of health outcomes: a cross-validated examination of health status measurement. Am J Public Health 1984; 74: 159–61
   PubMed Web of Science ®Google Scholar
• Landis R I, Heyman E R, Koch GG. Average partial association in three-way contingency tables: a review and discussion of alternative tests. Int Stat Rev 1978; 46: 237–54
   Web of Science ®Google Scholar
• Menkes C-J. Effects of disease-modifying anti-rheumatic drugs, steroids and non-steroidal anti-inflammatory drugs on acute-phase proteins in rheumatoid arthritis. Br J Rheumatol 1993; 32: 14–18, Suppl 3
   PubMedGoogle Scholar
• Blackburn W D, Prupas H M, Silverfield J C, Poiley J E, Caldwell J R, Collins RL, et al. Tenidap in rheumatoid arthritis. A 24-week double-blind comparison with hydroxychloroquine-plus-piroxicam and prioxicam alone. Arthritis Rheum 1995; 38: 1447–56
   PubMedGoogle Scholar
• Wylie G, Appelboom T, Bolten W, Breedveld F C, Feely J, Leeming M RG, et al. A comparative study of tenidap, a cytokine-modulating anti-rheumatic drug and diclofenac in rheumatoid arthritis: a 24-week analysis of a 1-year clinical trial. Br J Rheumatol 1995; 34: 554–63
   PubMedGoogle Scholar
• Breedveld F. Tenidap: a novel cytokine-modulating antirheumatic drug for the treatment of RA. Scand J Rheumatol 1994; 23: 31–44, Suppl 100
   Google Scholar
• Madhok R. Tenidap. Lancet 1995; 346: 481–5
   PubMed Web of Science ®Google Scholar
• Emery P. Early rheumatoid arthritis: time to aim for remission?. Arthritis Rheum 1995; 54: 944–7
   Google Scholar
• Genant H K, Kirby D S, Pickering E A, Loose L D, Weiner E S, Ting N. Tenidap slows X-ray deterioration in rheumatoid arthritis. Arthritis Rheum 1995; 38: S330, Suppl 9
   Google Scholar